4D制药ADR吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
226 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-06 02:46
235 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-30 02:46
198 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-25 05:35
200 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-24 21:38
200 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-02 06:44
271 0 公告 Notice of Effectiveness 4D制药ADR资讯 04-29 18:47
216 0 公告 [Cover]Correspondence 4D制药ADR资讯 04-26 00:00
214 0 公告 [Cover]SEC-generated letter 4D制药ADR资讯 04-26 00:00
341 0 公告 Registration statement by foreign private issuers 4D制药ADR资讯 04-22 04:39
408 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-05 00:44
373 0 公告 Securities to be offered to employees in employee 4D制药ADR资讯 04-02 05:26
370 0 公告 Annual and transition report of foreign private is 4D制药ADR资讯 04-01 05:55
324 0 公告 Notice of Effectiveness 4D制药ADR资讯 03-31 19:09
359 0 公告 [Amend] Registration statement by foreign private 4D制药ADR资讯 03-29 05:50
301 0 公告 [Cover]Correspondence 4D制药ADR资讯 03-28 00:00
577 1 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 03-23 23:13
415 0 公告 Registration statement by foreign private issuers 4D制药ADR资讯 03-09 06:32
379 0 公告 [Amend] Statement of acquisition of beneficial own 4D制药ADR资讯 03-03 07:58
416 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 03-01 06:44
403 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 02-26 07:33
422 0 公告 [Amend] Report of foreign issuer [Rules 13a-16 and 4D制药ADR资讯 02-19 06:34
454 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-19 06:26
399 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-19 06:26
383 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 02-18 21:29
435 0 公告 [Amend] Statement of acquisition of beneficial own 4D制药ADR资讯 02-03 23:51
494 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 02-03 07:02
498 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 02-03 05:05
424 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 01-11 05:00
426 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 01-11 05:00
382 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 01-06 05:15
465 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 12-15 00:46
452 0 公告 Notice of Effectiveness 4D制药ADR资讯 10-15 18:50
403 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 10-15 05:15
526 0 公告 [Amend] Registration statement for certain foreign 4D制药ADR资讯 10-07 18:26
500 0 公告 Post-Effective amendments for registration stateme 4D制药ADR资讯 10-01 18:51
476 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 10-01 18:42
472 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 10-01 18:31
493 0 公告 Notice of Effectiveness 4D制药ADR资讯 10-01 00:00
519 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 09-30 18:44
483 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 09-24 05:07
614 0 公告 Registration statement for certain foreign private 4D制药ADR资讯 09-14 19:32
461 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 08-12 03:47
552 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 08-02 23:41
575 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-28 05:48
457 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 07-28 04:50
780 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-08 00:29
506 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-05 04:17
478 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 05-26 02:36
465 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 05-26 02:17
534 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 05-25 21:10
502 0 公告 Notice of Effectiveness 4D制药ADR资讯 05-25 18:38
524 0 公告 Securities to be offered to employees in employee 4D制药ADR资讯 05-01 06:14
523 0 公告 [Amend] Annual and transition report of foreign pr 4D制药ADR资讯 05-01 05:39
550 0 公告 Registration statement for certain foreign private 4D制药ADR资讯 04-24 04:27
509 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-19 18:17
544 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-19 18:17
525 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 04-12 18:19
558 0 公告 Annual and transition report of foreign private is 4D制药ADR资讯 04-02 18:20
556 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-01 19:25
543 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 03-23 03:21
503 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-19 02:13
580 0 公告 Certification by an exchange approving securities 4D制药ADR资讯 03-18 22:13
464 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-18 05:03
481 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-17 21:54
484 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 03-09 05:35
608 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-01 21:00
529 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-01 21:00
535 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-26 21:41
520 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-26 21:34
505 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-26 21:28
520 0 公告 Notice of Effectiveness 4D制药ADR资讯 02-26 20:26
547 0 公告 Notice of Effectiveness 4D制药ADR资讯 02-26 20:15
638 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-25 06:59
365 0 公告 SEC Staff Letter: REDACTED EXHIBIT 4D制药ADR资讯 02-25 00:00
472 0 公告 Registration of securities [Section 12(b)] 4D制药ADR资讯 02-24 07:45
476 0 公告 [Cover]Correspondence 4D制药ADR资讯 02-24 00:00
419 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-19 00:00
402 0 公告 Registration of American Depository Receipt shares 4D制药ADR资讯 02-18 00:00
396 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-16 00:00
389 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-08 00:00
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
郑重声明:用户在社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500